Stay updated on Sitravatinib for Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib for Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib for Metastatic Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page footer was updated to reflect a newer ClinicalTrials.gov release revision (v3.5.3) instead of the prior version (v3.5.2).
    Difference
    0.1%
    Check dated 2026-04-24T05:47:14.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:29:55.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T04:53:39.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3, reflecting a new page version.
    Difference
    0.1%
    Check dated 2026-03-11T23:52:55.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces v3.4.1; no user-facing changes are evident.
    Difference
    0.1%
    Check dated 2026-02-11T14:12:33.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 on the page. No study content, eligibility criteria, or results appear to be affected.
    Difference
    0.1%
    Check dated 2026-02-04T10:27:17.000Z thumbnail image

Stay in the know with updates to Sitravatinib for Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib for Metastatic Breast Cancer Clinical Trial page.